time of new money to come in. End of year target $2+ with complete Ph 2a data coming.
plus they will release full 2a results end of year. Either way, stock will be WAY higher than $70M market cap by end of year.
damn ctixers..after losing on CTXS you come here with your back luck ?
only saving grace is that it has been selling off at lower than avg. volume.
better bounce at .33-34.
like I said last week...ctixers is the one selling last 2-3 days...a $200k sell can easily move the stock down 10% like it did...
no change in AVXL prospects...he just thought the other stock is a better buy right now. That is his decision.
NVIV: InVivo Enrolls Patient No. 3, Statistics Point To Evidence Of Clinical Benefit So Far.
its his first purchase in open market...he has started accumulating. Remember he has millions of shares already. So this is more sign of confidence than anything else. I bet he will buy more coming weeks.
Insider Transaction: $AVXL Automatic Purchase at $0.37 per share of 1000 shares by Officer Missling Christopher U on 2015-06-04.
just the start of the CEO buying up shares in his company ! This is great news.
wow you are grasping for anything..how does he know anything ? Is he the CEO's brother in law ?? Or he is one of the test patients in Austrialia ?
georgejj1 you are full of you know what..you are posting the same #$%$ on the other message board. You don't know anything. and stop posting irrelevant links to documents on the other board too.
KITE treats 1st patient for its phase 1/2...just treats, not cure ! Just for phase 1/2 ! and stock is up 10% at already multi billion valuations.
stock is such low valuation at under 30 mil, very positive news so far for 2 indications.